THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...
Recently, another modified one-stage method, developed by Owren, 7 has been given the distinctive name of thrombotest. Claims have been made that this test is more satisfactory for controlling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback